15 May 2019 --- To address the issue of muscle atrophy in senior populations, bioactive peptides player Nuritas has enlisted the expertise of Professor Luc van Loon from Maastricht University, in the Netherlands. The collaboration involves a double-blind placebo trial that will look at short term immobilization to measure muscle mass. This is an area of huge unmet medical need as there are no nutritional interventions that can preserve muscle mass and strength, according to van Loon.
